CUBE vs SLDB · P/E 25, rev $1.07B vs rev $8.1M
CubeSmart (CUBE) versus Solid Biosciences LLC (SLDB) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Solid Biosciences LLC (SLDB) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported SLDB revenue for 2022-12-31 was $8.1M. Net income was -$86.0M. SLDB currently screens at market cap $389.9M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. SLDB currently screens at market cap $389.9M.
Not investment advice. Open the CUBE and SLDB stock pages for the full models.
Not investment advice.